IBKS No3 SPAC

KQ:225430 Korea Asset Management
Market Cap
$7.77 Million
₩11.38 Billion KRW
Market Cap Rank
#31474 Global
#2081 in Korea
Share Price
₩408.00
Change (1 day)
+1.75%
52-Week Range
₩340.00 - ₩685.00
All Time High
₩4900.00
About

KMPHARMACEUTICAL Co.,Ltd. engages in the manufacture, wholesale, and retail of oral care, beauty care, and other daily necessities in South Korea and internationally. The company offers toothpastes, toothbrushes, cosmetics, masks, hand cream, toothbrush and toothpaste, kids toothbrush, and baby finger toothbrush sets. It also provides children's safety gargles, baby and light wipes, wet wipes, an… Read more

IBKS No3 SPAC (225430) - Total Liabilities

Latest total liabilities as of September 2025: ₩17.96 Billion KRW

Based on the latest financial reports, IBKS No3 SPAC (225430) has total liabilities worth ₩17.96 Billion KRW as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

IBKS No3 SPAC - Total Liabilities Trend (2015–2024)

This chart illustrates how IBKS No3 SPAC's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

IBKS No3 SPAC Competitors by Total Liabilities

The table below lists competitors of IBKS No3 SPAC ranked by their total liabilities.

Liability Composition Analysis (2015–2024)

This chart breaks down IBKS No3 SPAC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.38 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.60 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.38 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how IBKS No3 SPAC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for IBKS No3 SPAC (2015–2024)

The table below shows the annual total liabilities of IBKS No3 SPAC from 2015 to 2024.

Year Total Liabilities Change
2024-12-31 ₩16.36 Billion +8.50%
2023-12-31 ₩15.08 Billion +0.83%
2022-12-31 ₩14.95 Billion +17.10%
2021-12-31 ₩12.77 Billion +34.90%
2020-12-31 ₩9.47 Billion -50.04%
2019-12-31 ₩18.95 Billion +112.86%
2018-12-31 ₩8.90 Billion +497.00%
2017-12-31 ₩1.49 Billion +2.33%
2016-12-31 ₩1.46 Billion +2.42%
2015-12-31 ₩1.42 Billion --